NCT05892705View on ClinicalTrials.gov

Intrathecal Dexmedetomidine to Decrease Postoperative Nausea and Vomiting and Shivering.

PHASE4CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

January 15, 2023

Study Completion Date

January 15, 2023

Conditions

Intrathecal Dexmedetomidine

Interventions

DRUG

Dexmedetomidine Injection [Precedex]

intrathecal injection of 5 mcg dexmedetomidine

Trial Locations (1)

Unknown

Ain Shams University, Cairo

All Listed Sponsors

lead

Ain Shams University

OTHER